Article citationsMore>>
Tiruye, T., Ettridge, K., O’Callaghan, M., Moretti, K., Jay, A., Higgs, B., Santoro, K., Kichenadasse, G., Roder, D. and Beckmann, K. (2023) Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card. European Journal of Cancer Care, 2023, Article ID: 6660371.
https://doi.org/10.1155/2023/6660371
has been cited by the following article:
-
TITLE:
Aminated Cyclopropylmethylphosphonates as Potent Prostate Cancer Inhibitors
AUTHORS:
Abed Al Aziz Al Quntar, Ibrahim Abasy
KEYWORDS:
Prostate Cancer, Cancer, Cyclopropylphophonates, Aminophosphonates, Cyclopropanes, Phosphonates, Alkynylphosphonates, Anti-Cancer, Prostate
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.12 No.7,
July
23,
2024
ABSTRACT: Inspired by the anti-pancreatic promising results of our novel aminated cyclopropylmethylphosphonate compounds, an in vitro anti-prostate cancer activity exploration of these compounds was carried out on human prostate cancer cell line PC-3, and showed potent inhibiting activity at low micromolar concentrations (with an IC50 of approximately 45 μM).
Related Articles:
-
Emiddio Barletta, Lucia Cannella, Vincenza Tinessa, Domenico Germano, Bruno Daniele
-
Laurence Stephenson
-
A. N. Ghameshlou, A. Khodkar, R. Saei, S.M. Sheikholeslami
-
T. Velmurugan
-
Samuel Deem, Brian DeFade, Josh Lohri, James P. Tierney, Asmita Modak, Mary Emmett